REFERENCES
- Schutte J, Steegers E, Schuitemaker N, Santema J, de Boer K, Pel M,
Vermeulen G, Visser W, van Roosmalen J, the Netherlands Maternal
Mortality Committee. Rise in maternal mortality in the Netherlands.
BJOG 2010; 117: 399 – 406
- Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition
of severe and early-onset preeclampsia. Statements from the
International Society for the Study of Hypertension in Pregnancy
(ISSHP). Pregnancy Hypertens. 2013; 3:44–47. doi:
10.1016/j.preghy.2012.11.001
- Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstróm M et
al. Predictive value of the sFlt-1/PlGF ratio in women with suspected
preeclampsia. N Eng J Med 2016; 374: 13 - 22
- Schoofs K, Grittner U, Engels T, Pape J, Denk B, Henrich W and
Verlohren S. The importance of repeated measurements of the
sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine
growth restriction. J Perinat Med. 2014 Jan;42(1):61-8. doi:
10.1515/jpm-2013-0074
- Sabrià E, Lequerica-Fernández P, Lafuente P, Ángeles EE, Escudero AI,
Martínez-Morillo E, Álvarez FV. Use of the sFlt-1/PlGF ratio to rule
out preeclampsia requiring delivery in women with suspected disease.
Is the evidence reproducible? Clin Chem Lab Med 2018; 56: 303 – 311
- VanWijk MJ, Kublickiene K, Boer K and VanBavel E. Vascular function in
preeclampsia. Cardiovasc Res 2000; 47: 38 - 48
- Seong WJ, Kim SC, Hong DG, Koo TB, and Park IS. Amino-terminal
pro-brain natriuretic peptide levels in hypertensive disorders
complicating pregnancy. Hypertens Pregnancy 2011; 30: 287 - 294
- Álvarez-Fernández I, Prieto B, Rodríguez V, Ruano Y, Escudero AI and
Álvarez FV. N-terminal pro B-type natriuretic peptide and angiogenic
biomarkers in the prognosis of adverse outcomes in women with
suspected preeclampsia. Clin Chim Acta 2016; 463: 150 - 157
- Afshani N, Moustaqim-Barrette A, Biccard BM, Rodseth RN, Dyer RA.
Utility of B-type natriuretic peptides in preeclampsia: a systematic
review. Int J Obstet Anesth 2013; 22: 96 - 103
- Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, et al.
Evaluation of B-type natriuretic peptide (BNP) levels in normal and
preeclamptic women. Am J Obstet Gynecol 2005; 193: 450 – 454
- Johns, M.C., Stephenson, C. Amino-terminal pro-B-type natriuretic
peptide testing in neonatal and pediatric patients. Am J Cardiol 2008;
101: 76 - 81
- Sabrià E, Lequerica-Fernández P, Lafuente-Ganuza P, Eguia-Ángeles E ,
Escudero AI, Martínez-Morillo E, Barceló C and Álvarez FV. Addition of
N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine
kinase-1/placental growth factor ratio > 38 improves
prediction of pre-eclampsia requiring delivery within 1 week: a
longitudinal cohort study. Ultrasound Obstet Gynecol 2018; 51: 758 –
767
- American College of Obstetricians and Gynecologists; Task Force on
Hypertension in Pregnancy: Hypertension in pregnancy. Report of the
American College of Obstetricians and Gynecologists’ Task Force on
Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 122 – 131. DOI:
10.1097/01.AOG.0000437382.03963.88
- Zeger, S. L. and Liang, K-Y. Longitudinal data analysis for discrete
and continuous outcomes. Biometrics 1986; 42: 121 - 130
- R Development Core Team. R: A language and Environment for Statistical
Computing, R Foundation for Statistical Computing 2009, Vienna,
Austria. ISBN 3-900051-07-0. Available at: http://www.R-project.org.
Accessed on 3/2/2015
- Bates D, Mächler M, Bolker BM and Walker SC. Fitting Linear
Mixed-Effects Models Using lme4. Journal of Statistical Software
October 2015. doi: 10.18637/jss.v067.i01
- Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al.
pROC: an open-source package for R and S+ to analyze and compare ROC
curves. BMC Bioinformatics 2011; 7: 77
- Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing
risks model in early screening for preeclampsia by biophysical and
biochemical markers. Fetal Diagn Ther. 2013;33(1):8-15. doi:
10.1159/000341264
- Serra B, Mendoza M, Scazzocchio E, Meler E, Nolla M, Sabrià E,
Rodríguez I, Carreras E. A new model for screening for early-onset
preeclampsia, Am J Obstet Gynecol (2020), doi:
https://doi.org/10.1016/j.ajog.2020.01.020.
- Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco
Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS,
Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K,
Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus
placebo in pregnancies at high risk for preterm preeclampsia. N Engl J
Med 2017; 377: 613–622
- Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus
expectant management of severe preeclampsia at 28 to 32 weeks’
gestation: a randomized controlled trial. Am J Obstet Gynecol.
1994;171(3):818–822.
- Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or
expectant management for patients with severe preeclampsia between
28-34 weeks’ gestation: a randomized controlled trial. Obstet Gynecol.
1990;76(6):1070–1075.
- Vigil-De Gracia P, Reyes Tejada O, Calle Miñaca A, et al. Expectant
management of severe preeclampsia remote from term: the MEXPRE Latin
Study, a randomized, multicenter clinical trial. Am J Obstet Gynecol.
2013;209(5):425.e1–8
- Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in
different types of hypertensive pregnancy disorders and its prognostic
potential in preeclamptic patients. Am J Obstet Gynecol.
2012;206(1):58.e1–8.
- Enengl S, Mayer RB, Le Renard P-E, Shebl O, Arzt W, Oppelt P.
Retrospective evaluation of established cut-off values for the sFlt-
1/PlGF ratio for predicting imminent delivery in preeclampsia patients
Pregnancy Hypertension: An International Journal of Women’s
Cardiovascular Health(2020), doi:
https://doi.org/10.1016/jpregy.2020.01.009
- Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P,
Sabrià J et al. New gestational phase-specific cutoff values for the
use of the soluble fms-like tyrosine kinase-1/placental growth factor
ratio as a diagnostic test for preeclampsia. Hypertension 2014; 63:
346 – 352
- Cuckle H. Rational and irrational ratios. Ultrasound Obstet Gynecol
2016; 48: 275 – 278
- Verlohren S and Stepan H. Re: Rational and irrational ratios.
Ultrasound Obstet Gynecol 2017; 49: 157 – 160
- McCarthy FP,Gill C, Seed PT, Bramham K, Chappell LC and Shennan AH.
Comparison of three commercially available placental growth
factor-based tests in women with suspected preterm pre-eclampsia: the
COMPARE study. Ultrasound Obstet Gynecol 2019; 53: 62 – 67
- Verlohren S, Perschel FH, Thilaganathan B, Dröge LA, Henrich W,
Busjahn A and Khalil A. Angiogenic Markers and Cardiovascular Indices
in the Prediction of Hypertensive Disorders of Pregnancy.
Hypertension. 2017 Jun;69(6):1192-1197.
- Di Pasquo E, Ghi T, Dall’asta A,Angeli L, Fieni S, Pedrazzi G, Frusca
T. Maternal cardiac parameters can help in differentiating the
clinical profile of preeclampsia and in predicting progression from
mild to severe forms. AJOG 2019. doi:
https://doi.org/10.1016/j.ajog.2019.06.029